We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kimberly-Clark (KMB - Free Report) is a historic consumer packaged goods power within the broader paper products space. The Kleenex maker is under pressure amid rising costs and its 2022 forecast prompted some more selling of KMB shares.
Paper-Based Goods Titan
Kimberly-Clark’s various brands are household names in the U.S. and throughout much of the rest of the world. KMB’s portfolio includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Depend, GoodNites, Intimus, Neve, and tons of others. Crucially, many of these brands hold the No. 1 or No. 2 spot in terms of market share in the U.S. and beyond.
Kimberly-Clark is exposed to tissue paper, diapers, toilet paper, feminine care, and more. Its portfolio of essentials are hardly going out of style, but its growth days are long gone, with 2020’s 3.7% revenue expansion marking by far its strongest since 2011 as people stocked up on paper towels and more during the heart of the pandemic.
KMB’s 2021 revenue popped 2% but organic sales slipped 1%. Kimberly-Clark also ended last year on a somewhat sour note, with adjusted Q4 earnings down 23% YoY and fiscal 2021 EPS 20% off the pace.
Kimberly-Clark’s 2022 bottom-line guidance came in below Wall Street expectations, with the firm citing higher prices throughout much of its business. “Costs are projected to increase or remain elevated for most inputs including purchased raw materials as well as for distribution and energy.”
Image Source: Zacks Investment Research
Bottom Line
Kimberly-Clark’s FY22 consensus EPS estimates have dropped 10% since its late January financial release, with FY23 5% lower. The nearby chart showcases the CPG firm’s overall downward earnings revisions activity that helps KMB land a Zacks Rank #5 (Strong Sell) at the moment, alongside its “D” grade for Momentum in our Style Scores system.
KMB shares are down 7% in 2022 and are essentially flat over the past five years vs. the S&P 500’s 95% climb. Plus, the broader Consumer Products – Staples industry, which is in the bottom 11% of over 250 Zacks industries, has fallen 37% in the last three years.
All of this said, Kimberly-Clark operates a stable consumer staples business poised to keep on growing its top and bottom line for years if not decades to come. Plus, its 3.5% dividend yield blows away the 30-year U.S. Treasury’s 2.3%. Still, there appear to be other stronger options at the moment within retail, as KMB faces near-term setbacks.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Bear of the Day: Kimberly-Clark (KMB)
Kimberly-Clark (KMB - Free Report) is a historic consumer packaged goods power within the broader paper products space. The Kleenex maker is under pressure amid rising costs and its 2022 forecast prompted some more selling of KMB shares.
Paper-Based Goods Titan
Kimberly-Clark’s various brands are household names in the U.S. and throughout much of the rest of the world. KMB’s portfolio includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Depend, GoodNites, Intimus, Neve, and tons of others. Crucially, many of these brands hold the No. 1 or No. 2 spot in terms of market share in the U.S. and beyond.
Kimberly-Clark is exposed to tissue paper, diapers, toilet paper, feminine care, and more. Its portfolio of essentials are hardly going out of style, but its growth days are long gone, with 2020’s 3.7% revenue expansion marking by far its strongest since 2011 as people stocked up on paper towels and more during the heart of the pandemic.
KMB’s 2021 revenue popped 2% but organic sales slipped 1%. Kimberly-Clark also ended last year on a somewhat sour note, with adjusted Q4 earnings down 23% YoY and fiscal 2021 EPS 20% off the pace.
Kimberly-Clark’s 2022 bottom-line guidance came in below Wall Street expectations, with the firm citing higher prices throughout much of its business. “Costs are projected to increase or remain elevated for most inputs including purchased raw materials as well as for distribution and energy.”
Image Source: Zacks Investment Research
Bottom Line
Kimberly-Clark’s FY22 consensus EPS estimates have dropped 10% since its late January financial release, with FY23 5% lower. The nearby chart showcases the CPG firm’s overall downward earnings revisions activity that helps KMB land a Zacks Rank #5 (Strong Sell) at the moment, alongside its “D” grade for Momentum in our Style Scores system.
KMB shares are down 7% in 2022 and are essentially flat over the past five years vs. the S&P 500’s 95% climb. Plus, the broader Consumer Products – Staples industry, which is in the bottom 11% of over 250 Zacks industries, has fallen 37% in the last three years.
All of this said, Kimberly-Clark operates a stable consumer staples business poised to keep on growing its top and bottom line for years if not decades to come. Plus, its 3.5% dividend yield blows away the 30-year U.S. Treasury’s 2.3%. Still, there appear to be other stronger options at the moment within retail, as KMB faces near-term setbacks.